






















































2. グリア線維性酸性たんぱく（glial fibrillay acidic protein : GFAP）
3. 実験的脳梗塞（cerebral infarction model）





者は知的障害を合併しやすいことが知られており４, ７, 13, 18），
1998年に脳におけるfull-lengthジストロフィンの発現が
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It is now well known that dystrophin isoforms (427kDa, 260kDa, 140kDa, 116kDa, 71-75kDa) are widely
distributed throughout our body. In the central nervous system a considerable amount of Dp71 (71-75kDa)
is found in the perivascular cytoplasm of the astrocytes. However, the function of this dystrophin is still
unknown. To investigate the role of Dp71 in the brain tissue, cerebral infarction was induced in the control
(wild-type) mouse and mdx mouse which is known as an animal model of human muscle dystrophy
(Duchenne type), and morphological changes of the infarcted area were observed during repair of the
infarction. In addition, biochemical analysis of GFAP and Dp71 was carried out in the brain of the control
and mdx mouse.
In our present study, there were no differences in brain morphology between mdx and control mouse as
revealed in H-E stain and GFAP immunohistochemistry. However, the Dp71 were smaller in quantity in
the brain of the mdx mouse than that of the control mouse. The reaction of astrocytes during repair of
cerebral infarction was distinctly delayed in the mdx mouse compared with that of the control mouse.
These findings suggest that the astrocytes in the brain of the mdx mouse are functionally impaired
including perivascular cytoplasmic processes with relation to neo-vascularization.
